FDA to Propose Revisions to New Animal Drugs Regulations

Summary

The Food and Drug Administration (FDA) plans to propose changes to its regulations for new animal drugs under investigation and new animal drug applications (NADAs), aiming to streamline the review process while maintaining safety and effectiveness standards. The proposed revisions are part of the FDA's commitment to reform, as mandated by the Animal Drug Availability Act of 1996 (ADAA) and the President's National Performance Review.